Detection, isolation and characterization of principle synthetic route indicative impurity in telmisartan

Arabian Journal of Chemistry

Volumn 9, Issue , 2016, Pages S1516-S1522

  Srinivasan, V ^a   Sivaramakrishnan, H ^a   Karthikeyan, B ^b  

^a Piramal Enterprises Limited   (India)

^b ANNAMALAI UNIVERSITY   (India)

Author keywords

Characterization; HPLC; Impurity; MS; NMR; Telmisartan

Indexed keywords

CARBOXYLATION; CHARACTERIZATION; DRUG PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMPURITIES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ACTIVE PHARMACEUTICAL INGREDIENTS; HPLC; ISOLATION AND CHARACTERIZATION; NUCLEAR MAGNETIC SPECTROSCOPIES; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC); SYNTHETIC ROUTES; TELMISARTAN; THEORETICAL STUDY;

NUCLEAR MAGNETIC RESONANCE;

EID: 84859634331     PISSN: 18785352     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arabjc.2012.03.022     Document Type: Article

References (15)

1. Benson, S.C., Pershadsingh, H.A., Ho, C.I., Chittiboyina, A., Desai, P., Pravenec, M., Qi, N., Wang, J., Avery, M.A., Kurtz, T.W., Hypertension 43 (2004), 993–1002.
2. Engeli, S., Bohnke, J., Gorzelniak, K., Janke, J., Schling, R., Bader, M., Luft, F.C., Sharma, A.M., Hypertension 45 (2005), 356–362.
3. Lindholm, L.H., Ibsen, H., Dahlof, B., Devereux, R.B., Beevers, G., De Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S.E., Kristiansson, K., Lederballe-Pedersen, O., Nieminen, M.S., Omvik, P., Oparil, S., Wedel, H., Anurup, P., Edelman, J., Snapinn, S., Lancet 359 (2002), 1004–1010.
4. Merck Index, 14th ed. Merck & Co, Inc., USA, 2006, p. 1569.
5. Pople, J., et al., 1995. Gaussian 94, Revision C.2.
6. Potale, L.V., Damle, M.C., Khodke, A.S., Bothara, K.G., Int. J. Pharm. Sci. Rev. Res. 2:2 (2010), 35–39.
7. Sharma, A.M., Janke, J., Gorzelniak, K., Engeli, S., Luft, F.C., Hypertension 40 (2002), 609–611.
8. Shah, N.J., Suhagia, B.N., Shah, R.R., Shah, P.B., Ind. J. Pharm. Sci. 69 (2007), 202–205.
9. Torrealday, N., Gonzalez, L., Alonso, R.M., Jimenez, R.M., Lastra, E.O., J. Pharm. Biomed. Anal. 32 (2003), 847–857.
10. United States Pharmacopoeia, 2010. USP 33, First Supplement to the USP-NF Reissue, R-982.
11. Wankhede, S.B., Tajne, M.R., Gupta, K.R., Wadodkar, S.G., Ind. J. Pharm. Sci. 69:2 (2007), 298–300.
12. Yan, T., Li, H., Deng, L., Guo, Y., Yu, W., Fawcett, J.P., Zhang, D., Cui, Y., Gu, J., J. Pharm. Biomed. Anal. 48 (2008), 1225–1229.
13. Young, J.B., Dunlap, M.E., Pfeffer, M.A., Probstfield, J.L., Cohen-Solal, A., Dietz, R., Granger, C.B., Hradec, J., Kuch, J., McKelvie, R.S., McMurray, J.J., Michelson, E.L., Olofsson, B., Ostergren, J., Held, P., Solomon, S.D., Yusuf, S., Swedberg, K., Circulation 110 (2004), 2618–2626.
14. Yusuf, S., Teo, K.K., Pogue, J., Dyal, L., Copland, I., Schumacher, H., Dagenais, G., Sleight, P., Anderson, C., N. Engl. J. Med. 358 (2008), 1547–1559.
15. Zhang, H., Jiang, Y., Wen, J., Zhou, T., Fan, G., Wu, Y., J. Chromatogr. B 877 (2009), 3729–3733.